Skip to main content

Table 2 CMR, OCT and QCA characteristics

From: Plaque vulnerability of coronary artery lesions is related to left ventricular dilatation as determined by optical coherence tomography and cardiac magnetic resonance imaging in patients with type 2 diabetes

CMR data (n = 58)

LV-ejection fraction (%)

53.91 ± 8.11

LV-stroke volume (ml)

82.09 ± 20.20

Septum (mm)

12.05 ± 2.00

Lateral wall (mm)

10.09 ± 1.51

LV-ESV (ml)

75.33 ± 35.66

LV-ESV/BSA (ml/m2)

36.93 ± 17.12

LV-EDV (ml)

157.62 ± 50.95

LV-ESV/BSA (ml/m2)

77.18 ± 23.33

LV-EDD (mm)

51.40 ± 6.19

Left atrium (cm2)

23.65 ± 5.43

Right atrium (cm2)

21.81 ± 6.35

OCT data (n = 81)

OCT data measurement

Percent area stenosis (%)

74.37 ± 10.25

Stenosis length (mm)

7.11 ± 5.19

Mean reference area (mm2)

6.39 ± 2.11

Minimal luminal diameter (mm)

1.20 ± 0.30

Eccentricity lumen index (%)

23.54 ± 10.84

Minimal luminal area (mm2)

1.59 ± 0.80

OCT data plaque characteristic

Lipid plaque (n, %)

45 (55.5)

   - Lipid arc ( ° )

133.24 ± 40.26

   - Lipid plaque length (mm)

4.12 ± 2.27

   - Minimum fibrous cap thickness (μm)

82.14 ± 24.18

Mean fibrous cap thickness (μm)

132.66 ± 28.91

Calcium plaque (n, %)

58 (71.6)

Fibrous plaque (n, %)

66 (81.5)

Plaque rupture (n, %)

10 (12.3)

Thrombus (n, %)

5 (6.2)

Angiographic data (QCA) (n = 81)

Vessel investigated (n, %)

   - LAD

34 (42.0)

   - LCX

20 (24.7)

   - RCA

27 (33.3)

Diameter stenosis (%)

61.79 ± 15.64

Lesion length (mm)

8.68 ± 5.10

MLD (mm)

0.93 ± 0.43

RD (mm)

2.45 ± 0.62

  1. The data are presented as mean ± SD or n (%).
  2. Abbreviations: LAD left anterior descending coronary artery, LCX left circumflex coronary artery, RCA right coronary artery, MLD minimal luminal diameter, RD reference diameter, LV left ventricle, ESV end systolic volume, EDD end diastolic diameter, EDV end diastolic volume, NYHA New York Heart Association, BSA body surface area.